Literature DB >> 21311319

Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008.

Clare E French1, Gwenda Hughes, Amanda Nicholson, Mandy Yung, Jonathan D Ross, Tim Williams, Kate Soldan.   

Abstract

BACKGROUND: Pelvic inflammatory disease (PID) is difficult to define and diagnose; therefore, a standardized methodology for identifying and monitoring PID diagnoses is required. We estimated the rate of PID in general practice in England, and investigated variations by definition of PID, time, age, and geographical area.
METHODS: We analyzed the United Kingdom General Practice Research Database between 2000 and 2008. Definitions of "definite," "probable," and "possible" PID among female patients (aged 16 to 44 years) were determined according to medical codes that denoted diagnoses or symptoms indicative of PID. Diagnoses rates were calculated per 100,000 person-years (py). Trends were assessed using Poisson regression.
RESULTS: The rate of clinical PID diagnoses was 281/100,000 py (95% confidence interval [95% CI]: 277-286) for definite cases; 326/100,000 py (95% CI: 321-331) for definite and probable cases; and 1117/100,000 py (95% CI: 1107-1126) for definite, probable, and possible cases. During 2000 to 2008, the rate of definite/probable PID decreased by 10.4% per year (95% CI: 9.7-11.1; P<0.001). Rates declined in all areas and among all age groups with greatest decline in women aged 16 to 19 years. Meanwhile, the rate of possible PID increased.
CONCLUSIONS: The definition of PID used has a major effect on the rate and trends over time. There was heterogeneity in rates of definite/probable PID by age and region, but homogeneity with regard to a trend of declining rates. Ongoing monitoring of PID diagnoses, with standard case definitions, will contribute to the evaluation of chlamydia screening in England.

Entities:  

Mesh:

Year:  2011        PMID: 21311319     DOI: 10.1097/OLQ.0b013e3181f22f3e

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  18 in total

1.  Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial.

Authors:  C Cao; A Luo; P Wu; D Weng; H Zheng; S Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-06       Impact factor: 3.267

Review 2.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

Review 3.  Pelvic inflammatory disease.

Authors:  Jonathan D C Ross
Journal:  BMJ Clin Evid       Date:  2013-12-11

4.  Management of epididymo-orchitis in primary care: results from a large UK primary care database.

Authors:  Amanda Nicholson; Greta Rait; Tarita Murray-Thomas; Gwenda Hughes; Catherine H Mercer; Jackie Cassell
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

5.  Pelvic inflammatory disease: identifying research gaps--proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011.

Authors:  Toni Darville
Journal:  Sex Transm Dis       Date:  2013-10       Impact factor: 2.830

6.  Brazilian Protocol for Sexually Transmitted infections, 2020: pelvic inflammatory disease.

Authors:  Maria Luiza Bezerra Menezes; Paulo Cesar Giraldo; Iara Moreno Linhares; Neide Aparecida Tosato Boldrini; Mayra Gonçalves Aragon
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

7.  Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England.

Authors:  M J Price; A E Ades; N J Welton; I Simms; P J Horner
Journal:  Epidemiol Infect       Date:  2016-09-28       Impact factor: 4.434

8.  Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic.

Authors:  Ingrid V F van den Broek; Jolande A Land; Jan E A M van Bergen; Servaas A Morré; Marianne A B van der Sande
Journal:  Obstet Gynecol Int       Date:  2014-03-13

9.  Is secondary preventive care improving? Observational study of 10-year trends in emergency admissions for conditions amenable to ambulatory care.

Authors:  Martin Bardsley; Ian Blunt; Sian Davies; Jennifer Dixon
Journal:  BMJ Open       Date:  2013-01-02       Impact factor: 2.692

Review 10.  Mucosal immunity in the female genital tract, HIV/AIDS.

Authors:  Juliana Reis Machado; Marcos Vinícius da Silva; Camila Lourencini Cavellani; Marlene Antônia dos Reis; Maria Luiza Gonçalves dos Reis Monteiro; Vicente de Paula Antunes Teixeira; Rosana Rosa Miranda Corrêa
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.